Researchers have shown a statistically significant association between neuropsychological (NP) test performance and memory complaints in post-treatment, early stage breast cancer patients. Patient-reported memory difficulties were also associated with having received chemotherapy and radiation and depressive symptoms in one of the first studies to show patient complaints of cognitive problems after breast cancer treatment (chemo brain) associates with NP test performance.